September 2026 Research Update

This month added a clearer picture of how varied heart problems can be in Kabuki syndrome, and how much outcomes can depend on the specific heart anatomy. In a single-center group followed over many years, about half of children had congenital heart disease, and not all of them needed surgery. The most serious early outcomes were concentrated in children with more complex heart structures who underwent surgery. [1]

Among the children with heart disease who did have surgery, several different operations were used, reflecting that there is not one typical surgical path for Kabuki syndrome. Four of the 11 surgical patients died during the same hospitalization, and these deaths were mainly in children with single-ventricle physiology (a particularly complex type of heart structure). In contrast, no deaths were reported in the group managed without surgery, and there was no late mortality reported during follow-up in this cohort. [1]

For families, this mainly helps set expectations that heart findings in Kabuki syndrome range from issues that can be watched without surgery to complex conditions where surgery is part of care and early hospital risk can be higher. The information comes from routine care at one center (37 children total), so it cannot tell what will happen for any one child, but it does reinforce that anatomy and other health issues present at the same time may strongly shape surgical risk. This does not introduce a new treatment, but it adds concrete, long-term outcome information that may matter when discussing prognosis and planning around major heart procedures. [1]

Studies this month added detail to how social communication and behavior can look in Kabuki syndrome, including differences between KS1 (KMT2D) and KS2 (KDM6A). In caregiver reports from 35 individuals, peer relationship difficulties were common in the overall group. Reported autism diagnoses and autism-related characteristics were higher in KS2 than KS1 in this sample. [2]

The pattern of challenges also differed by genetic subtype in this report. KS1 was described as having its biggest challenges in restricted or repetitive behaviors, while several social areas were less affected and social motivation was rated within typical limits. KS2 was described as having broader difficulties across social areas compared with KS1, while restricted or repetitive behaviors and prosocial behaviors were reported as similar in severity between the groups. [2]

For patients and caregivers, this provides a more specific picture of day-to-day social experiences that may come with Kabuki syndrome, and it suggests that KS2 may more often involve wider social communication difficulties than KS1 in at least some families. Because the results are based on caregiver questionnaires at a single point in time, they cannot explain why these differences occur or predict an individual child's path, but they help clarify what kinds of difficulties are being reported across families. This is not a new diagnostic test or treatment, but it may matter over time as research works toward better, subtype-aware supports and outcome tracking. [2]

This month, laboratory research focused on building better models of Kabuki syndrome rather than testing treatments. A new KS1 missense mouse model reproduced several core features but did not reproduce some previously reported brain-related findings from a different KS1 model, suggesting that different genetic changes in KMT2D may lead to different patterns in research animals. A separate report created a patient-derived stem-cell line to support future studies in human cells. [3] [4]

In the KS1 mouse model carrying the R5230H change, the mice showed growth deficiency, craniofacial differences, and immune-related findings like low IgA and fewer Peyer's patches (immune tissue in the gut). The mice also had high perinatal lethality and unilateral kidney agenesis in a subset, while measures related to adult neurogenesis and certain learning tasks did not show the deficits seen in a prior loss-of-function model. The researchers also reported that KMT2D levels and global enzyme-related marks they measured were preserved in this model, which may help narrow down which biological pathways are disrupted by this specific missense change. [3]

The stem-cell report established an induced pluripotent stem cell (iPSC) line from one person with KS1 and a KMT2D frameshift variant. This kind of cell resource is meant to let scientists study disease processes in the lab using human-derived cells, but the report did not test therapies or link the cell line to patient outcomes. Its main contribution is making a tool that other studies can use. [4]

A single KS2 case report described a 15-month-old girl with a likely pathogenic KDM6A variant and several eye findings, including high myopic astigmatism (strong nearsightedness with uneven focus), eyelid abnormalities with exposure keratopathy (corneal irritation from incomplete eyelid closure), nystagmus, and optic disc hypoplasia. Brain imaging in this child also showed agenesis of the corpus callosum. Because it is one patient, it shows what can happen but cannot tell how common these findings are in KS2. [5]

For families, these reports mainly matter as steps toward better understanding Kabuki syndrome biology, rather than changes that affect care right now. The mouse and iPSC studies may matter later if they help researchers test ideas about why certain features develop or help screen potential therapies, but they do not predict outcomes for any specific person. The single KS2 case report may be useful as a reminder of the range of eye findings that can be seen in Kabuki syndrome, but it remains uncertain how often this exact combination occurs or how it relates to long-term vision in other children. [3] [4] [5]